MBI's media team has the skills and relationships with national and international print, online and broadcast media to get your story told.
MBI has a seasoned investor relations team and a proven track record of building or restoring credibility with investors and analysts.
MBI brings a fresh, strategic approach to business development for its clients within the biotechnology, medical device, and life sciences industries.
MBI specializes in branding and rebranding private and public life science companies. A clear and consistent corporate identity is the keystone to a successful communications plan.
Image Building | Visual Branding
MBI understands that corporate credibility is one of the most important assets a company can build and that it is one of the hardest to repair when damaged by a crisis.
There are over 1,000 life science industry conferences scheduled around the world each year... Learn More
12/17/14 - Poxel Announces Positive Top Line Results for Its Antidiabetic Agent Imeglimin in a Phase 2b Dose-Ranging Trial
12/15/14 - Annexon Bioscience Closes $34M Series A-1 Funding for Novel Approach to Neurodegenerative and Autoimmune Diseases
12/10/14 - Bavarian Nordic Reaches Enrollment Target in the Pivotal Phase 3 Study of PROSTVAC in Prostate Cancer
12/09/14 - Acetylon Pharmaceuticals Announces Ricolinostat Continues to Demonstrate Clinically Meaningful and Durable Disease Response Rates in Phase 1b Combination Studies in Multiple Myeloma
MacDougall Biomedical Clients in San Francisco
Come and schedule meetings with our clients during the week of January 13-16, 2014